The HeartMate 3™ LVAD, a mechanical circulatory support pump with Full MagLev™ Flow Technology has significantly advanced the field of LVAD therapy, setting the standard with innovation and outstanding clinical outcomes that make a …

The HeartMate 3™ LVAD is the most advanced LVAD yet. It is an advancing technology using Full MagLev™ Flow Technology, which helps protect the blood as it flows through the pump.

2022年10月7日 · HM3 is the most common durable LVAD currently being manufactured and implanted in the United States. While there are still some axial-flow HeartMate 2 and centrifugal-flow. HeartWare LVADs in circulation, recent studies showed improved outcomes with HM3 when compared to these devices prompting a transition to HM3. [PMID: 34980564]

rtMate 3TM Left Ventricular Assist System. The HeartMate Touch Communication System is required during implant procedures and any time clos monitoring of system operation is needed. It provides clinicians with the ability to program system parameters such as pump speed, assess and track alarm cond

The HeartMate 3™ LVAD is a small implantable device that is designed to support the pumping function of the heart and helps circulate blood throughout the body for patients whose hearts are too weak to pump blood adequately on their own.

The HM3 is a fully magnetically levitated LVAD and has 4 unique features: (1) a fully magnetically levitated rotor, (2) large blood flow pathways, (3) intrinsic pulsatility, and (4) an intradevice operating system. 10

2018年5月2日 · In this article, the surgical implantation technique for the latest-generation of intrapericardial, fully magnetically levitated centrifugal continuous-flow LVADs is described in detail for the HeartMate 3 system. Each step is illustrated by several sketches and surgically important steps are discussed.

Heartmate III (HM3) Left Ventricular Assist Device (LVAD) (Abbott Inc, Chicago IL) is a fully magnetically levitated centrifugal implantable pump used to treat chronic heart failure patients. The MOMENTUM trial demonstrated that patients treated ...

Objectives: Right ventricular failure following implantation of a durable left ventricular assist device (LVAD) is a major driver of mortality. Reported survival following biventricular (BiVAD) or total artificial heart (TAH) implantation remains substantially inferior to LVAD alone. We report our outcomes with LVAD and BiVAD HeartMate 3 (HM3).

2024年12月3日 · On June 25, 2014, the first Heartmate 3 (HM3, Abbott) left ventricular assist device (LVAD) implantation was performed at Hannover Medical School, Germany. 1 We now present the 10-year follow-up of the first-in-man HM3 patient.